박사현 교수
1577-5587
전문진료분야
비뇨기종양(전립선, 방광, 신장, 고환, 부신), 로봇수술, 혈뇨, PSA 상승, 요로결석
전화 예약
1577-5587
기본정보
학력
2003.03 ~ 2009.02울산대학교 의학 졸업 2013.03 ~ 2018.02울산대학교 대학원 의학석사 졸업 2020.03울산대학교 대학원 의학박사 졸업 |
경력
2009.03 ~ 2010.02서울아산병원 수련의 2010.03 ~ 2014.02서울아산병원 전공의 2017.05 ~ 2019.01서울아산병원 임상강사 2019.02 ~ 2020.09국립암센터 임상스텝전문의 2021.09 ~ 한림대학교강남성심병원 조교수 2021.09 ~ 한림대학교 의과대학 조교수 |
학회활동
대한비뇨의학회 대한비뇨기종양학회 대한전립선학회 |
수상이력
2012대한비뇨기종양학회 연제발표우수상 2017대한비뇨기종양학회 연제발표우수상 2020대한비뇨의학회 국외논문 기초 최우수상 |
논문
◎ 국내학회지 발표논문
1. Pak S, Kim M, Ahn H. Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea. Investigative and Clinical Urology. 2018;59:313-20.
2. Pak S, Park S, Ryu J, Hong S, Song SH, You D, et al. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean journal of urology. 2013;54:824-9.
◎ 국제학회지 발표논문
1. Pak S, You D, Jeong IG, Lee D-E, Kim SH, Joung JY, et al. Cause of Mortality After Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-Institutional Study in Korea. Cancer Research and Treatment. 2020.
2. Pak S, Suh YS, Lee D-E, Kim SH, Joung JY, Park WS, et al. Association between postoperative detection of circulating tumor cells and recurrence in patients with prostate cancer. The Journal of urology. 2020;203:1128-34.
3. Pak S, Kim MS, Park EY, Kim SH, Lee KH, Joung JY. Association of body composition with survival and treatment efficacy in castration-resistant prostate cancer. Frontiers in Oncology. 2020;10:558.
4. Kim H, Pak S, Park KJ, Kim M-h, Kim JK, Kim M, et al. Utility of multiparametric magnetic resonance imaging with PI-RADS, Version 2, in patients with prostate cancer eligible for active surveillance: which radiologic characteristics can predict unfavorable disease? Clinical Genitourinary Cancer. 2020;18:50-5.
5. Pak S, You D, Jeong IG, Song C, Lee J-L, Hong B, et al. Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2019;17:e420-e8.
6. Pak S, You D, Jeong IG, Song C, Lee J-L, Hong B, et al. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. Scientific reports. 2019;9:1-7.
7. Pak S, You D, Jeong IG, Kim YS, Hong JH, Kim C-S, et al. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer. International journal of clinical oncology. 2019;24:1238-46.
8. Pak S, Park SY, Shin TJ, You D, Jeong IG, Hong JH, et al. Association of muscle mass with survival after radical prostatectomy in patients with prostate cancer. The Journal of urology. 2019;202:525-32.
9. Pak S, Park S, Kim Y, Park J-H, Park C-H, Lee K-J, et al. The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. Journal of Experimental & Clinical Cancer Research. 2019;38:1-13.
10. Pak S, Park S, Kim M, Go H, Cho YM, Ahn H. The impact on oncological outcomes after radical prostatectomy for prostate cancer of converting soft tissue margins at the apex and bladder neck from tumour‐positive to‐negative. BJU international. 2019;123:811-7.
11. Pak S, Kim W, Kim Y, Song C, Ahn H. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. Journal of cancer research and clinical oncology. 2019;145:2293-301.
12. Kim M, Park M, Pak S, Choi SK, Shim M, Song C, et al. Integrity of the Urethral Sphincter Complex, Nerve-sparing, and Long-term Continence Status after Robotic-assisted Radical Prostatectomy. European urology focus. 2018.
13. Song SH, Park S, Chae SY, Moon DH, Park S, Kim KS. Predictors of Renal Functional Improvement After Pyeloplasty in Ureteropelvic Junction Obstruction: Clinical Value of Visually Assessed Renal Tissue Tracer Transit in (99m)Tc-mercaptoacetyltriglycine Renography. Urology. 2017;108:149-54.
14. Song SH, Pak S, Jeong IG, Kim KS, Park HK, Kim CS, et al. Outcomes of stent-change therapy for bilateral malignancy-related ureteral obstruction. International urology and nephrology. 2015;47:19-24.
15. Song SH, Pak S, Park S, Song C, Jeong IG, Choi HJ, et al. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging. The Journal of urology. 2014;192:402-8.
1. Pak S, Kim M, Ahn H. Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea. Investigative and Clinical Urology. 2018;59:313-20.
2. Pak S, Park S, Ryu J, Hong S, Song SH, You D, et al. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean journal of urology. 2013;54:824-9.
◎ 국제학회지 발표논문
1. Pak S, You D, Jeong IG, Lee D-E, Kim SH, Joung JY, et al. Cause of Mortality After Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-Institutional Study in Korea. Cancer Research and Treatment. 2020.
2. Pak S, Suh YS, Lee D-E, Kim SH, Joung JY, Park WS, et al. Association between postoperative detection of circulating tumor cells and recurrence in patients with prostate cancer. The Journal of urology. 2020;203:1128-34.
3. Pak S, Kim MS, Park EY, Kim SH, Lee KH, Joung JY. Association of body composition with survival and treatment efficacy in castration-resistant prostate cancer. Frontiers in Oncology. 2020;10:558.
4. Kim H, Pak S, Park KJ, Kim M-h, Kim JK, Kim M, et al. Utility of multiparametric magnetic resonance imaging with PI-RADS, Version 2, in patients with prostate cancer eligible for active surveillance: which radiologic characteristics can predict unfavorable disease? Clinical Genitourinary Cancer. 2020;18:50-5.
5. Pak S, You D, Jeong IG, Song C, Lee J-L, Hong B, et al. Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2019;17:e420-e8.
6. Pak S, You D, Jeong IG, Song C, Lee J-L, Hong B, et al. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. Scientific reports. 2019;9:1-7.
7. Pak S, You D, Jeong IG, Kim YS, Hong JH, Kim C-S, et al. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer. International journal of clinical oncology. 2019;24:1238-46.
8. Pak S, Park SY, Shin TJ, You D, Jeong IG, Hong JH, et al. Association of muscle mass with survival after radical prostatectomy in patients with prostate cancer. The Journal of urology. 2019;202:525-32.
9. Pak S, Park S, Kim Y, Park J-H, Park C-H, Lee K-J, et al. The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. Journal of Experimental & Clinical Cancer Research. 2019;38:1-13.
10. Pak S, Park S, Kim M, Go H, Cho YM, Ahn H. The impact on oncological outcomes after radical prostatectomy for prostate cancer of converting soft tissue margins at the apex and bladder neck from tumour‐positive to‐negative. BJU international. 2019;123:811-7.
11. Pak S, Kim W, Kim Y, Song C, Ahn H. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. Journal of cancer research and clinical oncology. 2019;145:2293-301.
12. Kim M, Park M, Pak S, Choi SK, Shim M, Song C, et al. Integrity of the Urethral Sphincter Complex, Nerve-sparing, and Long-term Continence Status after Robotic-assisted Radical Prostatectomy. European urology focus. 2018.
13. Song SH, Park S, Chae SY, Moon DH, Park S, Kim KS. Predictors of Renal Functional Improvement After Pyeloplasty in Ureteropelvic Junction Obstruction: Clinical Value of Visually Assessed Renal Tissue Tracer Transit in (99m)Tc-mercaptoacetyltriglycine Renography. Urology. 2017;108:149-54.
14. Song SH, Pak S, Jeong IG, Kim KS, Park HK, Kim CS, et al. Outcomes of stent-change therapy for bilateral malignancy-related ureteral obstruction. International urology and nephrology. 2015;47:19-24.
15. Song SH, Pak S, Park S, Song C, Jeong IG, Choi HJ, et al. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging. The Journal of urology. 2014;192:402-8.